Expanding the diversity of therapies in the pipeline and more efficiently recruiting patients for clinical trials will increase our odds of discovering a breakthrough. I’m hopeful it will lead to an intervention that reduces the impact of Alzheimer&

Expanding the diversity of therapies in the pipeline and more efficiently recruiting patients for clinical trials will increase our odds of discovering a breakthrough. I’m hopeful it will lead to an intervention that reduces the impact of Alzheimer’s.https://twitter.com/alzassociation/status/1191355165120585728 …